Job Description Summary
Implement and continuously improve the GR/IR E2E and related processes within accounts payable for Region Americas. In this role you will own the management of all Key Region Americas Suppliers, ensuring frequent and close relationship with procurement category managers /country heads and supplier representatives to align on processes, drive adherence to Novartis policies and strategies with positive impact on the Key metric/KPI related to the process (GR/IR) and Finance C process standardization
Job Description
-
Job Description
Your Key Responsibilities:
• Follow up mail to PO with items >90 days to PO owner (requester), guaranteeing actions plans, generating meetings with team involved and trying to close open items.
• Responsible to prepare and sent to approving WO according to LSI.
• Excellent attention to detail ensuring high-quality standards are implanted in our transactions and systems
• Reviewer/ Execution for sensitive transactions MR11, MRBR, MIGO and FBRA.
• Business User GRIR training.
• Ensure application of agreed Novartis control procedures and actively support to deliver SOX certification.Role Requirements :
• University level degree in business Accounting/Finance.
• 4+ years of experience in accounting, accounts payable or analyst role.
• Proficient in MS Office applications such as Word, Excel and Power Point
• Experience with SAP, or comparable systems, preferred.
• English and Spanish (advanced).
• Good analytical skills and problem-solving abilityNovartis is committed to building an outstanding, inclusive work environment and diverse teams' representative of the patients and communities we serve.
Skills Desired
Adaptability, Compliance And Controls, Continual Improvement Process, Critical Thinking, Data Cleansing / Normalization, Financial Accounting, Financial And Management Reporting, Group Problem Solving, Resilience Training, Taxes
Top Skills
What We Do
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
